Skip to main content

Life Sciences & Healthcare

FBC has developed broad expertise in the life sciences field. It represents the most prominent multinational and local players in a broad range of areas, including biopharmaceuticals, biotechnology, medical devices, medical services, genomics, diagnostics, medical IT and health care services, all in various stages of development. Clients range from medical device and bio-technology start-ups, to international “big pharma” companies, and venture capital funds that focus on life science and health care companies.

FBC regularly advises life sciences companies on both public and private equity and debt financings, mergers and acquisitions, research and development financing, and technology licensing, as well as on day-to-day matters.

FBC advises on life sciences and healthcare regulatory issues, including pharmaceuticals, biotechnology and medical devices. The practice counsels clients with regards to compliance with the Ministry of Health's requirements and the approval process for registration, labeling, importation, production, drug safety (pharmacovigilance) and product liability and marketing of pharmaceutical products in Israel.

FBC's practitioners maintain close ties with the venture capital funds, strategic players and private investors most active in this field and leverage the firm's relationships to assist its clients.

Dowload as PDF Hebrew 中文

Perrigo, a NYSE and TASE-traded company, in the Israeli aspects of its proxy fight against Mylan N.V.’s hostile takeover, the $8.6B acquisition of Elan Corporation and the reincorporation of Perrigo in Ireland, and in its earlier acquisition of Agis Industries

OrbiMed Fund, the world’s largest life sciences-dedicated fund, in certain Israeli law aspects of fund formation matters, various investments in public and private Israeli life science companies

Kamada, an Israeli publicly traded pharmaceutical company, in a $200M distribution, manufacturing and license agreement with Baxter and a $200M strategic distribution agreement with Chiesi Farmaceutici

Rainbow Fund, in a variety of strategic and financial transactions with leading players such as Medtronic, Abbott Laboratories, Sorin Group and Sony

Natali-Seculife Israel, Israel’s leading provider of emergency telemedicine and home help services to senior citizens and people requiring cardiac monitoring

Clal Biotechnology